Light Sciences Oncology's Unattributed - II Round

Light Sciences Oncology raised a round of funding on December 23, 2013.

Light Sciences Oncology (LSO) is developing Talaporfin Sodium for solid tumors as well as other indications such as BPH. Talaporfin Sodium is a water-soluble drug targeted by a small, single-use, disp…

Articles about Light Sciences Oncology's Unattributed - II Round: